nach oben

Digestive Diseases and Sciences

Erschienen in:

01.08.2012 | Original Article

Doppler Ultrasound of Hepatic Blood Flow for Noninvasive Evaluation of Liver Fibrosis Compared with Liver Biopsy and Transient Elastography

verfasst von: H. H. Lutz, N. Gassler, F. W. Tischendorf, C. Trautwein, J. J. W. Tischendorf

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Accurate quantification of liver fibrosis is essential for therapeutic decision-making and follow-up of chronic liver diseases.

Aims

To optimize the quality of non-invasive assessment of liver fibrosis in patients with chronic hepatopathy we compared Doppler ultrasound with liver histology and transient elastography (TE).

Methods

In this prospective observational study, we performed Doppler ultrasound of hepatic blood vessels as well as TE in 125 patients who underwent liver biopsy for diagnostic work-up of hepatopathy. Hepatic venous flow was evaluated by determining resistance index (HVRI) of the right hepatic vein. Doppler and TE results were compared with histological staging, grading and degree of steatosis obtained by liver biopsy.

Results

HVRI showed a high reliability in predicting fibrosis stage FII or higher (AUROC 93.7 %, HVRI < 1.185; sensitivity 89.66 % and specificity 86.32 %) and was superior to TE. Neither steatosis nor inflammation had significant influence on HVRI-based estimation of fibrosis (1.45 ± 0.2; 1.26 ± 0.05; 1.06 ± 0.06; 0.87 ± 0.08; 0.46 ± 0.11 for F0–FIV, respectively). HVRI differed significantly in different stages of fibrosis. In contrast, portal vein and hepatic artery only showed significant changes in higher stages of fibrosis. Hepatic artery resistance index was elevated (0.67–0.74; p < 0.05); portal vein flow maximum and undulation were significantly reduced in higher fibrosis (p < 0.05 and p < 0.01, respectively).

Conclusions

Hepatic blood flow analysis, especially HVRI, provides useful information during assessment of hepatopathy and is a reliable predictor of liver fibrosis stage FII or higher as part of the non-invasive diagnostic work-up and follow-up in chronic liver disease.

Germani G, Hytiroglou P, Fotiadu A, Burroughs AK, Dhillon AP. Assessment of fibrosis and cirrhosis in liver biopsies: an update. Semin Liver Dis. 2011;31:82–90.PubMedCrossRef

Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513–1520.PubMedCrossRef

Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology. 1996;24:289–293.PubMedCrossRef

Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350.PubMedCrossRef

Degos F, Perez P, Roche B, et al. Diagnostic accuracy of FibroScan® and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol. 2010;53:1013–1021.PubMedCrossRef

Coulden RA, Lomas DJ, Farman P, Britton PD. Doppler ultrasound of the hepatic veins: normal appearances. Clin Radiol. 1992;45:223–227.PubMedCrossRef

Colli A, Cocciolo M, Riva C, et al. Abnormalities of Doppler waveform of the hepatic veins in patients with chronic liver disease: correlation with histologic findings. AJR Am J Roentgenol. 1994;162:833–837.PubMed

Colli A, Fraquelli M, Andreoletti M, Marino B, Zuccoli E, Conte D. Severe liver fibrosis or cirrhosis: accuracy of US for detection—analysis of 300 cases. Radiology. 2003;227:89–94.PubMedCrossRef

von Herbay A, Frieling T, Haussinger D. Association between duplex Doppler sonographic flow pattern in right hepatic vein and various liver diseases. J Clin Ultrasound. 2001;29:25–30.CrossRef

10.

Bolondi L, Li Bassi S, Gaiani S, et al. Liver cirrhosis: changes of Doppler waveform of hepatic veins. Radiology. 1991;178:513–516.PubMed

11.

Ohta M, Hashizume M, Kawanaka H, et al. Prognostic significance of hepatic vein waveform by Doppler ultrasonography in cirrhotic patients with portal hypertension. Am J Gastroenterol. 1995;90:1853–1857.PubMed

12.

Kim MY, Baik SK, Park DH, et al. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study. Liver Int. 2007;27:1103–1110.PubMedCrossRef

13.

Sebastiani G, Halfon P, Castera L, et al. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C. Aliment Pharmacol Ther. 2011;35:92–104.PubMedCrossRef

14.

Abu-Yousef MM. Duplex Doppler sonography of the hepatic vein in tricuspid regurgitation. AJR Am J Roentgenol. 1991;156:79–83.PubMed

15.

Scheinfeld MH, Bilali A, Koenigsberg M. Understanding the spectral Doppler waveform of the hepatic veins in health and disease. Radiographics. 2009;29:2081–2098.PubMedCrossRef

16.

Menghini G, Lauro G, Caraceni M. Some innovations in the technic of the 1-s needle biopsy of the liver. Am J Gastroenterol. 1975;64:175–180.PubMed

17.

Pedersen JF, Madsen LG, Larsen VA, et al. A Doppler waveform index to characterize hepatic vein velocity pattern and evaluate hepatic fibrosis. J Clin Ultrasound. 2008;36:208–211.PubMedCrossRef

18.

Mihmanli I, Kantarci F, Yilmaz MH, et al. Effect of diffuse fatty infiltration of the liver on hepatic artery resistance index. J Clin Ultrasound. 2005;33:95–99.PubMedCrossRef

19.

Mohammadinia AR, Bakhtavar K, Ebrahimi-Daryani N, et al. Correlation of hepatic vein Doppler waveform and hepatic artery resistance index with the severity of nonalcoholic fatty liver disease. J Clin Ultrasound. 2010;38:346–352.PubMed

20.

Verveer C, Zondervan PE, Ten Kate FJ, Hansen BE, Janssen HL, de Knegt RJ. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int. 2012;32:622–628.PubMedCrossRef

21.

Myers RP, Pomier-Layrargues G, Kirsch R, et al. Discordance in fibrosis staging between liver biopsy and transient elastography using the fibroscan XL probe. J Hepatol. 2012;56:564–570.

22.

Gaia S, Carenzi S, Barilli AL, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011;54:64–71.PubMedCrossRef

23.

Harata M, Hashimoto S, Kawabe N, et al. Liver stiffness in extrahepatic cholestasis correlates positively with bilirubin and negatively with alanine aminotransferase. Hepatol Res. 2011;41:423–429.PubMedCrossRef

24.

Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan®) irrespective of fibrosis. Hepatology. 2008;48:1718–1723.PubMedCrossRef

25.

Kovac JD, Dakovic M, Stanisavljevic D, et al. Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases. Eur J Radiol. 2011;in press.

26.

Joka D, Wahl K, Moeller S, et al. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology. 2012;55:455–464.PubMedCrossRef

27.

Boursier J, de Ledinghen V, Zarski JP, et al. Comparison of 8 diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely non-invasive. Hepatology. 2012;55:58–67.

28.

Kim SY, Jeong WK, Kim Y, et al. Changing waveform during respiration on hepatic vein Doppler sonography of severe portal hypertension: comparison with the damping index. J Ultrasound Med. 2011;30:455–462.PubMed

29.

EASL Clinical Practice Guidelines. Management of hepatitis C virus infection. J Hepatol. 2011;55:245–264.CrossRef

30.

EASL Clinical Practice Guidelines. Management of chronic hepatitis B. Gastroenterol Clin Biol. 2009;33:539–554.CrossRef

31.

Dietrich CF, Lee JH, Gottschalk R, et al. Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. AJR Am J Roentgenol. 1998;171:437–443.PubMed

32.

Kim SU, Han KH, Park JY, et al. Liver stiffness measurement using FibroScan® is influenced by serum total bilirubin in acute hepatitis. Liver Int. 2009;29:810–815.PubMedCrossRef

33.

Sacerdoti D, Merkel C, Bolognesi M, Amodio P, Angeli P, Gatta A. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics. Gastroenterology. 1995;108:1152–1158.PubMedCrossRef

34.

Kok T, van der Jagt EJ, Haagsma EB, Bijleveld CM, Jansen PL, Boeve WJ. The value of Doppler ultrasound in cirrhosis and portal hypertension. Scand J Gastroenterol Suppl. 1999;230:82–88.PubMed

35.

Killi RM. Doppler sonography of the native liver. Eur J Radiol. 1999;32:21–35.PubMedCrossRef

36.

Salvatore V, Borghi A, Peri E, et al. Relationship between hepatic haemodynamics assessed by Doppler ultrasound and liver stiffness. Dig Liver Dis. 2012;44:154–159.

37.

Cosgrove DO, Arger PH, Coleman BG. Ultrasonic anatomy of hepatic veins. J Clin Ultrasound. 1987;15:231–235.PubMedCrossRef

Titel: Doppler Ultrasound of Hepatic Blood Flow for Noninvasive Evaluation of Liver Fibrosis Compared with Liver Biopsy and Transient Elastography
verfasst von: H. H. Lutz
N. Gassler
F. W. Tischendorf
C. Trautwein
J. J. W. Tischendorf
Publikationsdatum: 01.08.2012
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 8/2012
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-012-2153-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Doppler Ultrasound of Hepatic Blood Flow for Noninvasive Evaluation of Liver Fibrosis Compared with Liver Biopsy and Transient Elastography

Abstract

Background

Aims

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Background

Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2012

Single-Incision Versus Conventional Laparoscopy for Colorectal Disease: A Meta-Analysis

Effect of the Expression of Matrix Metalloproteases and Their Tissue Inhibitors on Survival of Patients with Resectable Colorectal Cancer

Balanced Propofol Sedation Versus Propofol Monosedation in Therapeutic Pancreaticobiliary Endoscopic Procedures

CD30 Ligand/CD30 Interaction Is Involved in Pathogenesis of Inflammatory Bowel Disease

Induction of Pancreatic Cancer Cell Apoptosis and Enhancement of Gemcitabine Sensitivity by RAP80 siRNA

Correlation of Epigenetic Aberrance with STAT3 Signaling Pathway in Gastric Carcinogenesis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin